Are electronic prescribing systems increasing the risk of ‘look-alike sound-alike’ medication errors? The answer is complex and multifaceted, and it's a question that has been hotly debated in the healthcare industry. On the one hand, electronic prescribing (ePMA) systems have been touted as a way to reduce medication errors by up to 30%. But on the other hand, there are numerous examples of errors occurring, particularly with look-alike sound-alike (LASA) medicines. So, what's the truth? In this article, I'll delve into the issue, exploring the potential risks and benefits of ePMA systems, and examining the role of technology in mitigating these risks. I'll also offer my own perspective on the matter, drawing on my experience as an expert in the field. First, let's consider the potential risks of ePMA systems. The examples cited in the source material highlight the dangers of LASA errors, where similar-sounding drugs can be prescribed in error. These errors can have serious consequences, as seen in the tragic case of three-week-old Sidra Aliabase, who died after being prescribed sodium acid phosphate instead of sodium chloride. The issue is further compounded by the fact that LASA errors can be difficult to detect, as they may not be immediately obvious to healthcare professionals. Now, let's consider the potential benefits of ePMA systems. Proponents argue that these systems can reduce medication errors by up to 30%, thanks to features like drop-down menus and automated checks. However, it's important to note that these benefits may be offset by the introduction of new types of errors, such as those related to drop-down menus and ambient voice technology (AVT). One of the key challenges with ePMA systems is the potential for under-reporting of errors. As the source material notes, only a small percentage of prescribing and administration errors are reported, making it difficult to gauge the true scale of the problem. This under-reporting can be attributed to a variety of factors, including the time and effort required to report errors and the lack of awareness among healthcare professionals. So, what can be done to mitigate the risks of LASA errors in ePMA systems? One solution is to implement features like tall-man lettering, which can help to distinguish between similar-sounding drugs. Another solution is to change how drugs are grouped, so that commonly known LASA pairs are not presented together in drop-down menus. For example, penicillamine and penicillin should be presented separately, to reduce the risk of errors. The integration of clinical decision support AI could also play a key role in preventing LASA errors. By applying logic and prompting healthcare professionals to double-check their prescriptions, AI could help to catch errors before they occur. However, it's important to note that AI is not a panacea, and there are potential risks associated with its use, such as the introduction of new types of errors related to AVT. In my opinion, the key to mitigating the risks of LASA errors in ePMA systems lies in a combination of solutions. This includes the implementation of features like tall-man lettering and changes to how drugs are grouped, as well as the integration of clinical decision support AI. However, it's also important to recognize the limitations of these solutions and to be prepared for the introduction of new types of errors. In conclusion, the question of whether ePMA systems are increasing the risk of LASA medication errors is a complex one, with potential risks and benefits on both sides of the equation. While it's clear that there are potential dangers associated with these systems, it's also clear that there are steps that can be taken to mitigate these risks. By implementing features like tall-man lettering, changing how drugs are grouped, and integrating clinical decision support AI, healthcare professionals can help to reduce the risk of LASA errors and improve patient safety. However, it's also important to recognize the limitations of these solutions and to be prepared for the introduction of new types of errors. Only through a combination of awareness, education, and technological innovation can we hope to reduce the risk of LASA errors and create a safer healthcare system for all.
